Raloxifene is a selective estrogen receptor modulator (SERM) used primarily to prevent osteoporosis in postmenopausal women and reduce the risk of invasive breast cancer. It mimics the effects of estrogen on bone density while blocking estrogen's effects on breast and uterine tissues, thus offering a dual benefit in women's health management.